Frailty can effectively indicate adverse perioperative outcomes in percutaneous nephrolithotomy: Study

Written By :  Jacinthlyn Sylvia
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2024-07-26 17:00 GMT   |   Update On 2024-07-27 07:08 GMT

A recent study published in Urolithiasis journal revealed that frailty is a major predictor of negative perioperative outcomes in older patients undergoing percutaneous nephrolithotomy (PCNL) which highlights the critical need to identify and address frailty in this population.

Kidney stones represent a significant health concern, particularly among older adults, with a notably higher prevalence in males over the age of 60. The development of kidney stones is influenced by several risk factors, including male sex, hypertension, obesity, diabetes, and various lifestyle choices. The complications associated with kidney stones can be severe, leading to conditions such as cardiovascular disease, chronic kidney disease, and end-stage renal disease. Among the treatment options, percutaneous nephrolithotomy stands out as the preferred method for managing complex kidney stones due to its high success rate and its ability to achieve a stone-free state, outperforming other treatments like shockwave lithotripsy and ureteroscopy.

Advertisement

The primary objective of this study is to assess the impact of frailty on perioperative outcomes in patients aged 60 and above who underwent PCNL. To achieve this, the study analyzes data from the US Nationwide Inpatient Sample (NIS) database, covering the years 2010 to 2020. The goal is to understand how frailty influences key perioperative outcomes within this older patient demographic.

The study employs a comprehensive methodology, classifying patients into low, medium, and high frailty risk groups using the hospital frailty risk score (HFRS). A total of 30,829 patients were included in the analysis, with the study focusing on various outcomes such as in-hospital mortality, unfavorable discharge, prolonged hospital stays, transfusion needs, hospital costs, and complications.

Advertisement

The findings of the study reveal that high frailty risk is significantly associated with poorer perioperative outcomes. Specifically, patients with a high frailty risk exhibited increased rates of in-hospital mortality, higher rates of unfavorable discharge, longer hospital stays, a greater need for transfusions, more complications, and higher total hospital costs. Frailty emerges as a strong predictor of adverse outcomes, highlighting the need for meticulous management of frail older patients undergoing PCNL.

In discussing the results, the study underscores the critical importance of recognizing and managing frailty in older patients to improve perioperative outcomes. Incorporating frailty assessments into preoperative evaluations could significantly enhance the predictive accuracy for in-hospital mortality and other complications, thereby improving patient care and outcomes.

Overall, frailty is a significant prognostic indicator of adverse outcomes in older patients undergoing PCNL. It is essential for medical professionals to consider frailty when planning and executing treatment for kidney stones in older adults to mitigate risks and enhance recovery. This study emphasizes the critical role of frailty in determining surgical outcomes, suggesting that tailored care plans are vital for this vulnerable population.

Source:

Chien, Y.-C., Chen, P.-H., & Chang, Y.-J. (2024). Impact of frailty on perioperative outcomes following percutaneous nephrolithotomy in older persons: evidence from the US Nationwide Inpatient Sample. In Urolithiasis (Vol. 52, Issue 1). Springer Science and Business Media LLC. https://doi.org/10.1007/s00240-024-01595-y

Tags:    
Article Source : Urolithiasis

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News